Synaffix and Mitsubishi Tanabe Pharma ink license agreement for ADC technology
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The site’s GMP Certification has been successfully renewed
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Increases speed to market for drug developers working on nucleic acid therapeutics
Acquisition expands high-value medical platform
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
Subscribe To Our Newsletter & Stay Updated